Who owns IRONWOOD PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ironwood Pharmaceuticals stock

Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Camden Asset Management 50M $49B 0% Sep 2023
 View chart
Wolverine Asset Management 34M $37M -13% Dec 2023
 View chart
Wellesley Investment Advisors 27M $29B 100% Dec 2023
 View chart
Balyasny Asset Management 25M $27M 100% Dec 2023
 View chart
Braidwell 16M $17M 0% Dec 2023
 View chart
Capstone Investment Advisors 15M $17M 0% Dec 2023
 View chart
Readystate Asset Management 12M $13M 0% Dec 2023
 View chart
Calamos Advisors 9.5M $10M 0% Dec 2023
 View chart
CSS 6.5M $7.1M 18% Dec 2023
 View chart
Jane Street 3.8M $4.0M 0% Dec 2023
 View chart
Jpmorgan Chase & Co 2.4M $2.6M 195% Dec 2023
 View chart
Shenkman Capital Management 2.1M $2.3B -36% Dec 2023
 View chart
FMR 2.0M $1.9M 100% Sep 2023
 View chart
Citigroup 249k $270k 0% Dec 2023
 View chart
Leucadia National Corporation 203k $198k 100% Sep 2023
 View chart
D.A. Davidson & Co. 135k $147k 100% Dec 2023
 View chart
HPM Partners 36k $39k 100% Dec 2023
 View chart
Multi-Financial Securities 32k $31k 0% Sep 2023
 View chart
Foresight Capital Management Advisors 26k $28k 100% Dec 2023
 View chart
Morgan Stanley 9.0k $8.7k 0% Sep 2023
 View chart
Boussard & Gavaudan Investment Management 6.6k $6.5M 0% Sep 2023
 View chart
Northwestern Mutual Wealth Management Company 6.0k $5.8k 0% Sep 2023
 View chart
Wells Fargo & Company 1.0k $1.1k 0% Dec 2023
 View chart

Who sold out of Ironwood Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2023 27M $27M
Deutsche Bank Aktiengesellschaft Sep 2023 100k $97k